Physician profile
Armando Wu
NPI 1700042561
$7,367.33
in general payments reported to CMS, 2019-2025
50 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $258 · 2022: $2,744 · 2023: $2,886 · 2024: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,365.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $886.60 | 2022-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $637.79 | 2021-2024 | Prolia, Evenity, Repatha |
| Abbvie INC. | $609.34 | 2021-2024 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $530.06 | 2021-2024 | Mounjaro, Emgality, Reyvow |
| Novartis Pharmaceuticals Corporation | $485.07 | 2022-2024 | |
| Glaxosmithkline, LLC. | $460.90 | 2022-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Organon LLC | $382.27 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $347.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $337.97 | 2021-2023 | |
| Novo Nordisk INC | $287.88 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Dexcom, INC. | $213.09 | 2022-2024 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Exact Sciences Corporation | $192.97 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $170.93 | 2023-2024 | |
| Stryker Corporation | $165.27 | 2023 | Clarifix Cryotherapy Device |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.32 | 2023-2024 | Xifaxan, Trulance |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $125.40 | 2023-2024 | Inspire |
| Gilead Sciences, INC. | $123.26 | 2021-2023 | |
| Hologic Sales and Service, LLC | $110.43 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.91 | 2021-2023 | Jardiance |
| Philips North America LLC | $88.51 | 2022-2024 | (Ck7) Extended Holter, (Ck4) Mcot |
| Phadia US INC. | $83.58 | 2024 | Immunocap |
| Bausch Health US, LLC | $79.50 | 2022-2023 | Aplenzin |
| Genzyme Corporation | $75.20 | 2024 | |
| Coopersurgical, INC. | $63.83 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Esperion Therapeutics, INC. | $57.59 | 2023-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $48.01 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $46.43 | 2021 | |
| Irhythm Technologies, INC. | $45.18 | 2024 | Zio Monitor, Zio Xt Patch |
| Astellas Pharma US INC | $45.14 | 2024 | Veozah |
| Baxter Healthcare | $40.85 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Alnylam Pharmaceuticals INC. | $40.48 | 2023 | Givlaari |
| Medline Industries LP | $26.69 | 2023 | |
| Amarin Pharma, INC. | $24.28 | 2022 | |
| Lundbeck LLC | $22.90 | 2022 | |
| Neurelis, INC. | $22.70 | 2024 | Valtoco |
| Teleflex LLC | $22.38 | 2023 | Urolift |
| Abbott Laboratories | $20.78 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $20.70 | 2021 | |
| Optinose US, INC. | $19.42 | 2024 | |
| Alfasigma USA, INC. | $17.73 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.51 | 2022 | |
| Merck Sharp & Dohme LLC | $16.48 | 2022 | |
| Merz North America, INC. | $15.69 | 2024 | |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Ibsa Pharma INC. | $15.61 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.21 | 2022 | |
| Shield Therapeutics INC | $14.48 | 2022 | |
| Phathom Pharmaceuticals, INC. | $14.12 | 2024 | Voquezna |
| Avion Pharmaceuticals | $13.87 | 2023 | Methylphenidate Hydrochloride |
| Sanofi Pasteur INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.